ES2031841T3 - Un procedimiento para la preparacion de derivados de 1,1-dioxido de 2-aminoalquil-1,2-benzoisotiazol-3-(2h)ona. - Google Patents

Un procedimiento para la preparacion de derivados de 1,1-dioxido de 2-aminoalquil-1,2-benzoisotiazol-3-(2h)ona.

Info

Publication number
ES2031841T3
ES2031841T3 ES198787103077T ES87103077T ES2031841T3 ES 2031841 T3 ES2031841 T3 ES 2031841T3 ES 198787103077 T ES198787103077 T ES 198787103077T ES 87103077 T ES87103077 T ES 87103077T ES 2031841 T3 ES2031841 T3 ES 2031841T3
Authority
ES
Spain
Prior art keywords
derivatives
aminoalkyl
dioxide
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787103077T
Other languages
English (en)
Inventor
Marcel Hibert
Maurice W. Gittos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2031841T3 publication Critical patent/ES2031841T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A DERIVADOS AROMATICOS DEL 2-AMINOALQUIL-1,2- BENZOISOTIAZOL-3(2H)ONA1,1-DIOXIDO DE FORMULA GENERAL (I) EN LA QUE X SE SELECCIONA ENTRE LOS GRUPOS (II), (III) Y (IV); N ES UN NUMERO ENTERO COMPRENDIDO ENTRE 2 Y 5; A Y B SON CADA UNO OXIGENO, AZUFRE O NR'' SIENDE R'' HIDROGENO O METILO; R1 ES H, OH O METOXI Y R2 ES H O METILO. TAMBIEN TRATA LA INVENCION DE SALES DE ADICION DE ACIDO DE LOS DERIVADOS DE FORMULA (I) Y DE UN PROCEDIMIENTO PARA SU PREPARACION Y EMPLEO COMO ANSIOLITICOS E HIPERTENSORES.
ES198787103077T 1986-03-05 1987-03-04 Un procedimiento para la preparacion de derivados de 1,1-dioxido de 2-aminoalquil-1,2-benzoisotiazol-3-(2h)ona. Expired - Lifetime ES2031841T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/836,276 US4748182A (en) 1986-03-05 1986-03-05 Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents

Publications (1)

Publication Number Publication Date
ES2031841T3 true ES2031841T3 (es) 1993-01-01

Family

ID=25271606

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787103077T Expired - Lifetime ES2031841T3 (es) 1986-03-05 1987-03-04 Un procedimiento para la preparacion de derivados de 1,1-dioxido de 2-aminoalquil-1,2-benzoisotiazol-3-(2h)ona.

Country Status (20)

Country Link
US (1) US4748182A (es)
EP (1) EP0236930B1 (es)
JP (1) JPH0780861B2 (es)
KR (1) KR900000674B1 (es)
CN (1) CN1016061B (es)
AR (1) AR243172A1 (es)
AT (1) ATE57921T1 (es)
AU (1) AU588977B2 (es)
CA (1) CA1287351C (es)
DE (1) DE3765803D1 (es)
DK (1) DK111787A (es)
ES (1) ES2031841T3 (es)
FI (1) FI88390C (es)
GR (1) GR3001311T3 (es)
HU (1) HU201064B (es)
IL (1) IL81739A0 (es)
NO (1) NO167391C (es)
NZ (1) NZ219457A (es)
PT (1) PT84407B (es)
ZA (1) ZA871448B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
US5300523A (en) * 1988-07-28 1994-04-05 Bayer Aktiengesellschaft Substituted aminomethyltetralins and their heterocyclic analogues
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
US5202572A (en) * 1988-09-21 1993-04-13 Fuji Xerox Co., Ltd. Thin film transistor
GB8907865D0 (en) * 1989-04-07 1989-05-24 Wyeth John & Brother Ltd Tetrahydroquinoline derivatives
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
JPH04507095A (ja) * 1989-05-04 1992-12-10 サノフィ 蛋白分解酵素阻害剤として有用なサッカリン誘導体及びその製造
IE903410A1 (en) * 1989-10-09 1991-04-10 Novo Nordisk As Indole derivatives, their preparation and use
US5177096A (en) * 1989-10-25 1993-01-05 Smithkline Beecham Corporation Substituted 5-((tetrazolyl)alkenyl)imidazoles and pharmaceutical methods of use thereof
DE4003541C1 (es) * 1990-02-06 1991-08-08 Alter S.A., Madrid, Es
DK37790A (da) * 1990-02-13 1991-08-14 Novo Nordisk As Indolderivater, deres fremstilling og anvendelse
US5194439A (en) * 1990-04-06 1993-03-16 John Wyeth & Brother Limited N-(2,3-dihydro-1,4-benzodioxinyl)-N-substituted aminopyrido-fused cycloalkanes
FR2661177A1 (fr) * 1990-04-23 1991-10-25 Rhone Poulenc Sante Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant.
EP0492021A1 (en) * 1990-12-24 1992-07-01 Merrell Dow Pharmaceuticals Inc. Use of certain 1,2-benzoisothiazol-3(2H)-1,1-dioxide derivatives in the treatment of depression and mania
WO1992011011A1 (en) * 1990-12-24 1992-07-09 Merrell Dow Pharmaceuticals Inc. Use of certain glutarimide derivatives in the treatment of depression and mania
DE4120322A1 (de) * 1991-06-20 1992-12-24 Bayer Ag Aminomethyl-substituierte 2,3-dihydropyrano(2,3-b)pyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5134140A (en) * 1991-06-21 1992-07-28 American Home Products Corporation Psychotropic benzofuran derivatives
US5221745A (en) * 1991-06-21 1993-06-22 American Home Products Corp. Psychotropic piperidinylmethyl benzodioxans
US5126366A (en) * 1991-06-21 1992-06-30 American Home Products Corporation Aminophenoxyalkyl derivatives of benzodioxan
US5189171A (en) * 1991-06-21 1993-02-23 American Home Products Corporation Antipsychotic benzodioxan derivatives
US5182292A (en) * 1991-06-21 1993-01-26 American Home Products Corporation Psychotropic piperidinylmethyl benzodioxans
US5212170A (en) * 1991-06-21 1993-05-18 American Home Products Corporation Psychotropic piperidinylmethyl benzodioxans
US5166367A (en) * 1991-06-21 1992-11-24 American Home Products Corporation Antipsychotic benzodioxan derivatives
US5126367A (en) * 1991-06-21 1992-06-30 American Home Products Corporation Psychotropic benzodioxan derivatives
ZA931343B (en) * 1992-03-06 1993-09-24 Akzo Nv 1,4-dioxino(2,3-b)pyridine derivatives.
US5235055A (en) * 1992-09-02 1993-08-10 American Home Products Corporation Antipsychotic quinoline derivatives of benzodioxanmethylamine
US5245051A (en) * 1992-09-03 1993-09-14 American Home Products Corporation Antipsychotic chroman derivatives of benzodioxanmethylamine
RU2118322C1 (ru) * 1993-07-05 1998-08-27 Дюфар Интернэшнл Рисерч Б.В. 2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли
DE19522088A1 (de) * 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
CZ20024199A3 (cs) 2000-05-25 2004-01-14 F. Hoffmann-La Roche Ag Substituované 1-aminoalkyllaktamy a jejich použití jako antagonisty muskarinového receptoru
DE10254596A1 (de) * 2002-11-22 2004-06-03 Merck Patent Gmbh Indolderivate
MX2007009783A (es) 2005-02-17 2007-08-22 Wyeth Corp Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilfusionados.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2751392A (en) * 1953-11-23 1956-06-19 Geschickter Fund Med Res Tertiary amine derivatives of nu-and omicron-saccharin
US3711474A (en) * 1969-07-31 1973-01-16 Procter & Gamble Heterocyclic nitrogen-and sulfur-containing optical brightener compounds and detergents and bleach compositions containing same
US4104387A (en) * 1977-05-23 1978-08-01 E. R. Squibb & Sons, Inc. 3-(Arylcycloiminoalkyl)benzisothiazole 1,1-dioxides
US4110449A (en) * 1977-05-23 1978-08-29 E. R. Squibb & Sons, Inc. 2-substituted benzisothiazol-3-ones
CA1117533A (en) * 1978-02-03 1982-02-02 Peter C. Wade Benzisothiazole-1,1-dioxides
US4337250A (en) * 1979-07-30 1982-06-29 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4405622A (en) * 1980-10-16 1983-09-20 Syntex (U.S.A.) Inc. [1-(1,4-Benzodioxan-2-yl)-4-(4-aminopyrimidin-2-yl]piperazines useful as anti-depressants
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
CA1244418A (en) * 1984-07-30 1988-11-08 Marcel Hibert Glutarimide antianxiety and antihypertensive agents

Also Published As

Publication number Publication date
FI88390C (fi) 1993-05-10
CN1016061B (zh) 1992-04-01
PT84407B (pt) 1989-10-04
AU6960687A (en) 1987-09-10
ATE57921T1 (de) 1990-11-15
EP0236930A1 (en) 1987-09-16
AR243172A1 (es) 1993-07-30
PT84407A (en) 1987-04-01
NO167391C (no) 1991-10-30
DE3765803D1 (de) 1990-12-06
ZA871448B (en) 1987-08-20
NO167391B (no) 1991-07-22
FI870926A (fi) 1987-09-06
CA1287351C (en) 1991-08-06
NO870890D0 (no) 1987-03-04
US4748182A (en) 1988-05-31
KR900000674B1 (ko) 1990-02-02
DK111787D0 (da) 1987-03-04
JPH0780861B2 (ja) 1995-08-30
FI88390B (fi) 1993-01-29
AU588977B2 (en) 1989-09-28
DK111787A (da) 1987-09-06
GR3001311T3 (en) 1992-08-31
HU201064B (en) 1990-09-28
HUT47104A (en) 1989-01-30
FI870926A0 (fi) 1987-03-03
JPS62221678A (ja) 1987-09-29
EP0236930B1 (en) 1990-10-31
CN87101689A (zh) 1987-10-28
KR870008880A (ko) 1987-10-21
NZ219457A (en) 1989-09-27
IL81739A0 (en) 1987-10-20
NO870890L (no) 1987-09-07

Similar Documents

Publication Publication Date Title
ES2031841T3 (es) Un procedimiento para la preparacion de derivados de 1,1-dioxido de 2-aminoalquil-1,2-benzoisotiazol-3-(2h)ona.
ES2053508T3 (es) Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
ES2221440T3 (es) Derivados de acido aminofenoxiacetico como neuroprotectores.
ES2043625T3 (es) Derivados de acido ariloxicarboxilico, su preparacion y empleo.
ES2044934T3 (es) Derivados de acido fenil-sustituido-2-propenoicos de utilidad en agricultura.
ES2133163T3 (es) Esteres (o tioesteres) del acido n-acilsulfamico y esteres (o tioesteres) del acido n-sulfonilcarbamico como agentes hipercolesterolemicos.
ES2032899T3 (es) Agente cosmetico para aplicacion externa y su uso.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2033049T3 (es) Procedimiento para preparar derivados de oxa- o tia-zolina.
ES2046196T3 (es) Derivados de azacicloalcanos, promotores de absorcion que contienen los derivados como ingrediente eficaz y preparaciones externas que contienen los promotores de absorcion.
ES2051843T3 (es) Un proceso para la preparacion de un derivado del acido benzoilaminofenoxibutanico.
DK1284D0 (da) Substituerede 4-aminomethylen-chromaner eller -chromener eller syreadditionssalte deraf, deres fremstilling og anvendelse
ES2159734T3 (es) Derivados 2-heteroarilalquenilicos del acido ciclopentano-heptan(en)oico como agentes terapeuticos para el tratamiento de la hipertension ocular.
ES2009785B3 (es) Procedimiento para preparar derivados de tioxantona.
ES2026669T3 (es) Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos.
ES2038679T3 (es) Un procedimiento para preparar derivados de dihidrobenzofurano- y cromano-carboxamidas.
ES2032339T3 (es) Procedimiento para preparar nuevos compuestos de indolilpiperidina.
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
ES2064328T3 (es) Indolilpropanoles, procedimiento para su fabricacion y su uso, asi como preparaciones que contienen los compuestos.
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
ES2038708T3 (es) Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.
ES2128554T3 (es) Nuevos derivados del acido glutamico, procedimiento para su preparacion y su utilizacion como medicamentos para el aumento de la memoria y aprendizaje.
ATE76405T1 (de) 2-trifluormethyl-benzimidazole.
ES2046218T3 (es) Derivados de acidos piridin-2,4- y -2,5-dicarboxilicos, procedimientos para su produccion, aplicacion de los mismos asi como medicamentos a base de estos compuestos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 236930

Country of ref document: ES